NCT00981877

Brief Summary

The purpose of this study is to determine the effect of probiotics in rotavirus acute diarrhea in children. The investigators will compare the effect of two different probiotics products.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2007

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2008

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

September 18, 2009

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 22, 2009

Completed
Last Updated

September 22, 2009

Status Verified

September 1, 2009

Enrollment Period

8 months

First QC Date

September 18, 2009

Last Update Submit

September 21, 2009

Conditions

Keywords

acute diarrhearotavirusprobioticchildren

Outcome Measures

Primary Outcomes (1)

  • Duration of diarrhea

    within the first 72 hours during hospitalization

Secondary Outcomes (3)

  • Duration of fever

    the first 72 hours during hospitalization

  • Duration of vomiting

    the first 72 hours during hospitalization

  • Duration of hospitalization

    4 days

Study Arms (3)

1

ACTIVE COMPARATOR

This group will receive S. Boulardii Probiotic and Oral rehydration as needed

Drug: GB (Florestor)

2

ACTIVE COMPARATOR

This group will receive a mixed Probiotic preparation and oral rehydration as needed

Drug: GRALB

3

PLACEBO COMPARATOR

This group will receive a placebo, and oral rehydration as needed

Drug: GC (placebo)

Interventions

S. Boulardii preparation of 1 gram twice daily for 5 days

Also known as: Florestor, Bioflora
1
GRALBDRUG

mixed probiotic preparation 1 gram twice daily for 5 days.

Also known as: Probiotik, mixed probiotic
2

Placebo 1 gram twice daily for 5 days.

Also known as: Placebo
3

Eligibility Criteria

Age1 Month - 23 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Positive stool sample for rotavirus test

You may not qualify if:

  • Severe malnourishment
  • Severe dehydration
  • Use of antibiotics, probiotics or nitazoxanide 2 weeks before admission
  • Systemic infections
  • Severe chronic disease
  • Mixed enteric infections besides rotavirus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Pediatrico Albina Patino

Cochabamba, Departamento de Cochabamba, Bolivia

Location

Related Publications (7)

  • Smithline HA, Donnino M, Greenblatt DJ. Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects. BMC Clin Pharmacol. 2012 Feb 4;12:4. doi: 10.1186/1472-6904-12-4.

  • Waldvogel S, Pedrazzini B, Vaucher P, Bize R, Cornuz J, Tissot JD, Favrat B. Clinical evaluation of iron treatment efficiency among non-anemic but iron-deficient female blood donors: a randomized controlled trial. BMC Med. 2012 Jan 24;10:8. doi: 10.1186/1741-7015-10-8.

  • Savolainen-Kopra C, Haapakoski J, Peltola PA, Ziegler T, Korpela T, Anttila P, Amiryousefi A, Huovinen P, Huvinen M, Noronen H, Riikkala P, Roivainen M, Ruutu P, Teirila J, Vartiainen E, Hovi T. Hand washing with soap and water together with behavioural recommendations prevents infections in common work environment: an open cluster-randomized trial. Trials. 2012 Jan 16;13:10. doi: 10.1186/1745-6215-13-10.

  • Wiseman V, Mangham LJ, Cundill B, Achonduh OA, Nji AM, Njei AN, Chandler C, Mbacham WF. A cost-effectiveness analysis of provider interventions to improve health worker practice in providing treatment for uncomplicated malaria in Cameroon: a study protocol for a randomized controlled trial. Trials. 2012 Jan 6;13:4. doi: 10.1186/1745-6215-13-4.

  • Husebye EE, Lyberg T, Opdahl H, Aspelin T, Stoen RO, Madsen JE, Roise O. Intramedullary nailing of femoral shaft fractures in polytraumatized patients. a longitudinal, prospective and observational study of the procedure-related impact on cardiopulmonary- and inflammatory responses. Scand J Trauma Resusc Emerg Med. 2012 Jan 5;20:2. doi: 10.1186/1757-7241-20-2.

  • Pontes-Arruda A, Martins LF, de Lima SM, Isola AM, Toledo D, Rezende E, Maia M, Magnan GB; Investigating Nutritional Therapy with EPA, GLA and Antioxidants Role in Sepsis Treatment (INTERSEPT) Study Group. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double-blinded, controlled study: the INTERSEPT study. Crit Care. 2011 Jun 9;15(3):R144. doi: 10.1186/cc10267.

  • Grandy G, Medina M, Soria R, Teran CG, Araya M. Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect Dis. 2010 Aug 25;10:253. doi: 10.1186/1471-2334-10-253.

MeSH Terms

Conditions

DiarrheaRotavirus Infections

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsReoviridae InfectionsRNA Virus InfectionsVirus DiseasesInfections

Study Officials

  • Richard M Soria, MD

    Centro Pediatrico Albina Patino

    STUDY DIRECTOR
  • Giuseppe E Grandy, Md

    Centro Pediatrico Albina Patino - Instituto de Nutricion y Tecnologia de los Alimentos

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 18, 2009

First Posted

September 22, 2009

Study Start

July 1, 2007

Primary Completion

March 1, 2008

Study Completion

March 1, 2008

Last Updated

September 22, 2009

Record last verified: 2009-09

Locations